Plenary II
Integrated Chinese-Western Medicine
Chairperson: Prof ZHANG Zhang-jin, Board Member, Hospital Authority, Hong Kong, The People's Republic of China
*P2.1充分發揮兩種醫學優勢,推動中西醫結合高品質發展
(Leveraging the Strengths of Both Medical Systems to Advance High-Quality Development of Integrated Traditional Chinese and Western Medicine)
孟慶彬 國家中醫藥管理局醫政司司長
Mr Meng Qingbin, Director General, Department of Medical Administration, National Administration of Traditional Chinese Medicine, The People's Republic of China
*P2.2 人工智能與網絡藥理學在中西醫結合中的應用
(Application of Artificial Intelligence (UNIQ System"中醫藥原理智慧解讀系統") and Network Pharmacology on Integration of Chinese and Western Medicine)
李梢院士, 歐洲科學與藝術學院院士, 清華大學北京市中醫藥交叉研究所所長, 清華大學長聘教授
Prof LI Shao, Member of European Academy of Sciences and Arts; Director, Institute of TCM-X, Tenured Professor, Tsinghua University, The People's Republic of China
* Presentation in Putonghua
Plenary II
Integrated Chinese-Western Medicine
Chairperson: Prof ZHANG Zhang-jin, Board Member, Hospital Authority, Hong Kong, The People's Republic of China
*P2.1充分發揮兩種醫學優勢,推動中西醫結合高品質發展
(Leveraging the Strengths of Both Medical Systems to Advance High-Quality Development of Integrated Traditional Chinese and Western Medicine)
孟慶彬 國家中醫藥管理局醫政司司長
Mr Meng Qingbin, Director General, Department of Medical Administration, National Administration of Traditional Chinese Medicine, The People's Republic of China
*P2.2 人工智能與網絡藥理學在中西醫結合中的應用
(Application of Artificial Intelligence (UNIQ System"中醫藥原理智慧解讀系統") and Network Pharmacology on Integration of Chinese and Western Medicine)
李梢院士, 歐洲科學與藝術學院院士, 清華大學北京市中醫藥交叉研究所所長, 清華大學長聘教授
Prof LI Shao, Member of European Academy of Sciences and Arts; Director, Institute of TCM-X, Tenured Professor, Tsinghua University, The People's Republic of China
* Presentation in Putonghua
Grand Hall HA Convention 2025 hac.convention@gmail.comTechnical Issues?
If you're experiencing playback problems, try adjusting the quality or refreshing the page.
Questions for Speakers?
Use the Q&A tab to submit questions that may be addressed in follow-up sessions.